Conduct disorders in children and adolescents
128 results
1 - 100
Conduct disorders in children and adolescents 
Family and parenting interventions in children and adolescents with conduct disorder and delinquency aged 10‐17- Family and parenting interventions in children and adolescents with conduct disorder and delinquency aged 10-17
- Psychiatric evaluation and referral to treatment of adolescents
- Psychopharmacotherapy in children and adolescents
- Psychotherapeutic forms of treatment for children and adolescents
- Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents: Cochrane systematic review
- ADHD
- Itch in a child
- Aripiprazole for autism spectrum disorders (ASD)
- Antidepressants for functional abdominal pain disorders in children and adolescents
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- Bullying at school
- Newer generation antidepressants for depressive disorders in children and adolescents
- Self-destructive behaviour in childhood and adolescence
- Antiepileptics for aggression and associated impulsivity
- Family therapy for attention‐deficit disorder or attention‐deficit/hyperactivity disorder in children and adolescents
- Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- Client feedback in psychological therapy for children and adolescents with mental health problems
- Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents
- Psychological therapies for children and adolescents exposed to trauma
- Pharmacotherapy for anxiety disorders in children and adolescents: Cochrane systematic review
- Psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises
- Adolescent substance abuse
- The effect of parental mental illness on the child
- Recognition of alcohol and drug abuse
- Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
- Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes: Cochrane systematic review
- Omega‐3 fatty acid supplementation for depression in children and adolescents
- Pharmacotherapy for trichotillomania
- Comparative effectiveness of psychological interventions for treating the psychological consequences of sexual abuse in children and adolescents: a network meta‐analysis
- Obsessive-compulsive disorder (OCD) in children
- Atypical antipsychotics for disruptive behaviour disorders in children and youths
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
- Adolescent psychosis
- Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises
- Valproate for acute mania
- Psychological therapies for the management of chronic and recurrent pain in children and adolescents
- Psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions
- Antidepressants for generalised anxiety disorder (GAD): Cochrane systematic review
AAN guideline for treating insomnia in children and adolescents with autism spectrum disorder- Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents
- Antiepileptics for aggression and associated impulsivity: Cochrane systematic review
- Methylphenidate for children and adolescents with autism spectrum disorder
- Aripiprazole alone or in combination for acute mania
- Cognitive behavioural therapy for anxiety disorders in children and adolescents
- Community‐based interventions for improving mental health in refugee children and adolescents in high‐income countries
- Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years
- Personalised interventions for subgroups of children with conduct problems
- New generation antidepressants for depression in children and adolescents: a network meta‐analysis
- Task‐oriented interventions for children with developmental co‐ordination disorder
- Surgery for the treatment of obesity in children and adolescents
- E‐Health interventions for anxiety and depression in children and adolescents with long‐term physical conditions
- Alternatives to inpatient mental health care for children and young people
- Cognitive behavioural therapy (CBT), third‐wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents
- Drug interventions for the treatment of obesity in children and adolescents
- Braces for idiopathic scoliosis in adolescents
- Aripiprazole alone or in combination for acute mania: Cochrane systematic review
- Cognitive-behavioural interventions for children who have been sexually abused: Cochrane systematic review
- Psychological and social interventions for the promotion of mental health in people living in low‐ and middle‐income countries affected by humanitarian crises
- Primary‐level and community worker interventions for the prevention of mental disorders and the promotion of well‐being in low‐ and middle‐income countries
- The effectiveness and adverse effects of D‐cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder
- A patient with intellectual disability (ID) in a medical consultation
- Treatment Foster Care for improving outcomes in children and young people
- Oxcarbazepine for acute affective episodes in bipolar disorder: Cochrane systematic review
- Interventions for childhood apraxia of speech
- Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD): Cochrane systematic review
- Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders
- Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
- Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
- Clozapine versus other atypical antipsychotics for schizophrenia